COVID-19 – National Information
Recommendations in Spanish of the Spanish Myeloma Group (GEM/Pethema) for the treatment of myeloma patients during the COVID-19 outbreak. Read more.
To try and mitigate the impact of changing capacity, and to minimise the risk that the immunosppressive effects of myeloma therapy has, the guidance in the below document has been compiled on 25th March 2020 to help support myeloma doctors in their decision-making and treatment planning in the UK. Read more.